Abstract
Background:
Patients with Chronic Kidney Disease (CKD) undergoing hemodialysis experience psychological symptoms due to the stressful process and are likely to engage in fewer health-promoting behaviors.Objectives:
This study aimed to compare health-promoting behaviors and psychological distress in hemodialysis patients and healthy individuals during the COVID-19 pandemic.Methods:
This case-control study was conducted on 139 hemodialysis patients who visited the dialysis unit of Shahid Beheshti Hospital in Iran County and 139 healthy controls between 2020 and 2021. A demographic form, the Hospital Anxiety Depression Scale (HADS), the Health Promoting Lifestyle Profile II (HPLPII), and the Coronavirus Anxiety Scale (CAS) were used to collect data. Data analysis was performed in SPSS version 22, and a P-value of less than 0.05 was considered statistically significant.Results:
The mean age of the hemodialysis participants was 56.79 ± 13.97, and that of healthy participants was 56.89 ± 13.87 (P = 0.99). The mean score of health-promoting behaviors was significantly lower in hemodialysis patients than in healthy participants (120.53 ± 20.35 vs. 125.92 ± 6.76) (P = 0.005). Furthermore, hospital anxiety-depression (20.49 ± 5.20 vs. 15.28 ± 2.95) and coronavirus anxiety (22.83 ± 7.19 vs. 20.77 ± 4.71) were significantly higher in hemodialysis patients than in healthy participants (P < 0.001 and P = 0.001, respectively).Conclusions:
Hemodialysis patients exhibited lower health-promoting behaviors and higher coronavirus anxiety and depression than healthy individuals.Keywords
Renal Dialysis Kidney Failure Chronic Health Behavior Anxiety Depression
1. Background
The number of people with Chronic Kidney Disease (CKD) is increasing every year (1), leading to more CKD patients needing Renal Replacement Therapy (RRT) (2). According to Pender's theory, health-promoting behaviors include any measure taken to increase or maintain the level of health and self-actualization in a person or group (3). Health-promoting behaviors consist of six dimensions, namely spiritual growth, health responsibility regarding self and society, interpersonal relations to promote the social dimension of health, stress management to prevent physical and mental illnesses, physical activity, and healthy nutrition to maintain health in daily life (4). Patients on RRT often experience mood disorders and lower quality of life. Quality of life has an inverse relationship with anxiety and depression (5). Lifelong dependence on dialysis therapy, high mortality rates, and patients' adaptability to the condition can cause physical, social, and economic changes besides psychological effects such as depression, anxiety, despair, fatigue, lower quality of life, and a higher suicide rate (6).
Depression is the most important and common psychiatric disorder in End-stage Renal Disease (ESRD) patients. Dialysis patients' depression not only affects mortality (7), but they also experience a higher rate of hospitalization (8) and withdrawal from dialysis (9). Depression is also associated with lower quality of life and higher cardiovascular complications (10). Suicide ideation or attempt is significantly higher in dialysis patients than in the general population (11). A meta-analysis study reported the point prevalence rate of depression to be 22.8% in CKD patients, which was higher than the depression rate in the general population (12.9%) (12).
Depression is less diagnosed in hemodialysis patients because healthcare providers who provide facilities, treatment, and routine measures for these patients may not pay attention to depression control due to the nature of their disease (13). Regular depression screening must be conducted in this population because both depression and anxiety are strongly associated with the patient's quality of life (14).
Anxiety is a common but often neglected psychiatric symptom in patients with ESRD undergoing hemodialysis (HD) therapy (15). The exact prevalence of anxiety disorders is unclear in hemodialysis patients, but different studies have provided estimates of about 12 to 52% (16). Fear of the unknown has always been anxiety-provoking for humans. The insufficient scientific information about COVID-19 exacerbates this anxiety. During this era, people are looking for more information to overcome their anxiety. Anxiety can make people unable to distinguish between right and wrong, and thus, they may be exposed to false news (17).
2. Objectives
As early screening of anxiety and depression in hemodialysis patients for performing necessary interventions can help improve their quality of life (18), the present study aimed to compare health-promoting behaviors and psychological distress between hemodialysis patients and those without hemodialysis during the COVID-19 pandemic.
3. Methods
This case-control study was conducted on 139 hemodialysis patients who visited a referral teaching hospital in Mazandaran province, Iran, between 2020 and 2021. The inclusion criteria were individuals over the age of 18, physical ability to answer questionnaires, and informed consent. The exclusion criteria were incurable diseases, patient non-cooperation, non-consent, and severe psychiatric disorders. As there was no data on the mean (SD) of the Health Promoting Lifestyle Profile in two groups of participants in the previous study, we used a previous study that assessed depression and anxiety in hemodialysis patients (19). Also, we calculated the sample size of the participants based on the Health Promoting Lifestyle Profile of the patients on a pilot study at the beginning of the study with the following formula:
Where I ±= 0.5;
After inserting the equation, the minimum number of necessary samples was determined to be 139 patients undergoing hemodialysis at Shahid Beheshti Hospital in Babol City. Also, 139 healthy individuals were included in the study using the convenience sampling method.
In this study, the project manager (a medical student) invited patients who met the inclusion criteria and were visiting the dialysis unit to participate. During an interview session with the patients waiting for hemodialysis, the researcher checked their inclusion criteria and invited them to participate if they were eligible. The patient's demographic information was collected after obtaining their consent and completing the informed consent forms. To prevent fatigue in patients and increase the accuracy of data collection, the questionnaires were completed in two consecutive dialysis sessions. In the first session, the Hospital Anxiety Depression Scale (HADS) (14 questions) and the Coronavirus Anxiety Scale (CAS) (18 questions) were completed after an interview to obtain their personal information. In the second session, the Health Promoting Lifestyle Profile II (HPLPII) questionnaire (52 questions) was completed.
For the control group, the researcher went to the nephrology clinic of the same hospital and examined those who were homogeneous with the case group in terms of gender, age, education level, and important underlying diseases (e.g., diabetes, hypertension, hyperlipidemia, and thyroid diseases). Individuals who met the inclusion criteria were invited to participate. The data collection tools for the control group included the HPLPII questionnaire, the HADS, and the CAS.
The HPLPII questionnaire consisted of 52 questions designed by Walker in 1990. This questionnaire measures health responsibility, nutrition, physical activity, stress management, and interpersonal relations on a 4-point Likert scale: "never = 1, sometimes = 2, often = 3, and always = 4". Walker et al. (1990) confirmed the reliability of the lifestyle questionnaire as 0.86, 0.86, 0.8, 0.85, 0.79, and 0.87 for the six scales and 0.94 for the entire questionnaire using Cronbach's alpha (20). The validity and reliability of the questionnaire were also confirmed in Iranian studies. Confirming the construct validity, Pourmidani et al. reported the correlation between the subscales of this questionnaire between 0.67 and 0.80, and Mohammadi Zeidi et al. reported between 0.27 and 0.86. Also, the content validity of this tool has been qualitatively confirmed by Fathi Ashtiani and Jafari Kandovan (21-23). The reliability of this questionnaire has been confirmed in Iranian studies. In Mohammadi Zeidi et al.'s study, the Cronbach's alpha coefficient of the questionnaire for the whole tool was 0.82, and its dimensions were between 0.64 and 0.91, and in Fathi Ashtiani and Jafari Kandovan's study, it was 0.96. mentioned (22, 23).
The HADS was utilized as a tool in this research. This scale was first introduced by Zigmond and Snaith in 1983 as a method for screening psychiatric disorders in public outpatient clinics. The HADS measures depression and anxiety in outpatients simultaneously. The internal consistency of this measurement subscale was indicated by the measurement of Cronbach's alpha for the seven items of the depression subscale (Alpha = 0.70) and seven items of the anxiety subscale (24). Each question on this scale is scored from 0 to 3; hence, the scores of the depression and anxiety subscales range from 0 to 21 in the HADS. Higher scores indicate higher anxiety and depression. The validity of this questionnaire has been confirmed in Iranian studies. In Montazeri's study, assessing the validity by comparing the known groups showed satisfactory results. Both anxiety and depression subscales discriminated well between subgroups of patients who differed in clinical status (25). The face and content validity of the questionnaire has been confirmed by Kaviani et al. (24). The reliability of this questionnaire has been confirmed in Iranian studies. Amini et al. reported 0.866 and 0.735 coefficients, Montazeri et al. calculated 0.78 and 0.86 coefficients, and Kaviani obtained 0.85 and 0.70 coefficients for Cronbach's alpha of anxiety and depression subscales (24-26).
The CAS was another data collection tool used in the present study. Among Iranian researchers, Alipour et al. designed this scale in 2020, and it is scored on a 4-point Likert scale (never = 0, sometimes = 1, often = 2, and always = 3). The minimum and maximum scores for this tool are 0 and 54, respectively. A higher score indicates higher anxiety. The face and content validity of this tool was confirmed qualitatively. The reliability of this tool is 0.879 for the first dimension (psychological), 0.861 for the second dimension (physical), and 0.919 for the entire tool, using Cronbach's alpha method (27).
We used SPSS22 software for data analysis. Descriptive results were displayed in a table (absolute and relative frequency). The Kolmogorov-Smirnov test was utilized to examine the normality of data distribution. All variables in the results had P > 0.05, indicating the normality of data distribution. Therefore, parametric tests were used for data analysis. The t-tests were utilized to examine the differences in the total mean scores and different scopes of the questionnaires.
The present study was approved by the Ethics Committee of Babol University of Medical Sciences, with the code IR.MUBABOL.REC.1399.296. The researchers explained the purpose of the research to the participants, and they signed informed consent forms. The researchers committed themselves to observing the ethical principles of the Declaration of Helsinki. They guaranteed that the patient's personal information would remain confidential. The researchers also ensured that participation in the study was voluntary and would not affect the patient's care and treatment process. The participants had the right to leave the study. The researchers sought to comply with the principles of the Committee on Publication Ethics (COPE).
4. Results
Two hundred seventy-eight individuals participated in the present study, among whom 139 were assigned to the case group, and 139 were assigned to the control group. All research units were present until the end of the study; hence, there was no drop-out in the sample size.
Of the total participants, 122 were male, and 156 were female. One hundred forty participants were illiterate. Regarding job status, most (N = 145) were housewives. Most of them (N = 228) were married, and the majority (N = 225) lived in the city. The mean age of the control group (56.89 ± 13.87) did not have a significant difference from that of the case group (56.79 ± 13.97) (P = 0.99).
The chi-square test was used to examine the different frequencies of demographic characteristics and medical history between patients undergoing hemodialysis and healthy participants. The results indicated a significant difference between the two groups in terms of job status, marital status, and history of Ischemic Heart Disease (IHD) (Table 1).
Frequency of Demographic Characteristics and Medical History of the Participants
| Variables | Healthy Individuals | Hemodialysis Patients | P-Value |
|---|---|---|---|
| Gender | 0.18 | ||
| Male | 55 (39.6) | 67 (48.2) | |
| Female | 84 (60.4) | 72 (51.8) | |
| Education level | 0.86 | ||
| Illiterate | 71 (51.1) | 69 (49.6) | |
| Primary school | 35 (25.2) | 31 (22.3) | |
| High school diploma | 21 (15.1) | 25 (18.0) | |
| Higher than diploma | 12 (8.6) | 14 (10.1) | |
| Job | 0.003 | ||
| Employee | 10 (7.2) | 9 (6.5) | |
| Self-employed | 30 (21.6) | 23 (16.5) | |
| Farmer | 0 (0) | 6 (4.3) | |
| Unemployed | 15 (10.8) | 30 (21.6) | |
| Housewife | 82 (59.0) | 63 (45.3) | |
| Other | 2 (1.4) | 8 (5.8) | |
| Marital status | 0.001 | ||
| Single | 8 (5.8) | 12 (8.6) | |
| Married | 108 (77.7) | 120 (86.3) | |
| Divorced | 1 (0.7) | 4 (2.9) | |
| Widowed | 22 (15.8) | 3 (2.2) | |
| Place of residence | 0.36 | ||
| City | 116 (83.5) | 109 (78.4) | |
| Village | 23 (16.5) | 30 (21.6) | |
| History of visiting a psychiatrist | 0.06 | ||
| Yes | 2 (1.4) | 9 (6.5) | |
| No | 137 (98.6) | 130 (93.5) | |
| History of psychiatric disease | 0.99 | ||
| Yes | 2 (1.4) | 3 (2.2) | |
| No | 137 (98.6) | 136 (97.8) | |
| History of using psychiatric drugs | 0.99 | ||
| Yes | 6 (4.3) | 5 (3.6) | |
| No | 133 (95.7) | 134 (96.4) | |
| History of addiction | 0.49 | ||
| Cigarette | 7 (5.0) | 6 (4.3) | |
| Opioids | 5 (3.6) | 2 (1.4) | |
| No history | 127 (91.4) | 131 (94.2) | |
| History of ischemic heart disease | <0.001 | ||
| Yes | 24 (17.3) | 59 (42.4) | |
| No | 115 (82.7) | 80 (57.6) | |
| History of hyperlipidemia | 0.30 | ||
| Yes | 38 (27.3) | 47 (33.8) | |
| No | 101 (72.7) | 92 (66.2) | |
| History of hypertension | 0.28 | ||
| Yes | 98 (70.5) | 107 (77.0) | |
| No | 41 (29.5) | 32 (23.0) | |
| History of diabetes | 0.54 | ||
| Yes | 51 (36.7) | 57 (41.0) | |
| No | 88 (63.3) | 82 (59.0) | |
| History of thyroid disease | 0.13 | ||
| Yes | 16 (11.5) | 26 (18.7) | |
| No | 123 (88.5) | 113 (81.3) |
Among the 139 patients undergoing hemodialysis, the majority (N = 41) had been undergoing hemodialysis for 2 - 3 years. Moreover, 91.4% of the patients underwent hemodialysis three times a week, and 92 (66.2%) underwent hemodialysis for four hours each time. Hypertension was the leading cause of hemodialysis (55.4%) (Table 2).
Frequency of Dialysis Features in Hemodialysis Participants
| Variables | Frequency (%) |
|---|---|
| History of dialysis, y | |
| ≤ 1 | 36 (25.9) |
| 2 - 3 | 41 (29.5) |
| 4 - 6 | 31 (22.3) |
| ≥ 7 | 31 (22.3) |
| Dialysis frequency per week | |
| Once | 1 (0.7) |
| Twice | 11 (7.9) |
| Three times | 127 (91.4) |
| Dialysis duration in each session, h | |
| 3 | 47 (33.8) |
| 4 | 92 (66.2) |
| Cause of dialysis | |
| Hypertension | 77 (55.4) |
| Diabetes | 38 (27.3) |
| Polycystic kidney | 5 (3.6) |
| Kidney failure | 12 (8.6) |
| Kidney stone | 1 (0.7) |
| Hydronephrosis | 2 (1.4) |
| Kidney infection | 2 (1.4) |
| Alport syndrome | 1 (0.7) |
| Lupus | 1 (0.7) |
The two groups differed significantly in terms of the total scores of all questionnaires, and they were also significantly different in all fields, except for interpersonal relations and nutrition in the HPLP questionnaire. In other words, the healthy individuals showed significantly more health-promoting behaviors, and the hemodialysis patients showed more hospital anxiety-stress and coronavirus anxiety (Table 3).
Comparison of the Mean Scores of the Psychological Questionnaires and Their Different Domains in Control (Without Hemodialysis) and Case Groups (with Hemodialysis) a
| Variables | Healthy Individuals | Hemodialysis Patients | P-Value |
|---|---|---|---|
| HPLPII | |||
| Spiritual growth | 22.55 ± 2.58 | 20.48 ± 4.41 | <0.001 |
| Health responsibility | 21.45 ± 3.31 | 22.96 ± 4.61 | 0.002 |
| Interpersonal relations | 23.73 ± 2.71 | 23.09 ± 4.57 | 0.16 |
| Stress management | 18.22 ± 2.34 | 16.70 ± 3.51 | <0.001 |
| Physical activity | 16.91 ± 2.98 | 14.86 ± 4.86 | <0.001 |
| Nutrition | 23.07 ± 2.90 | 22.45 ± 4.38 | 0.11 |
| Total | 125.92 ± 6.76 | 120.53 ± 20.35 | 0.005 |
| Coronavirus Anxiety Scale (CAS) | 20.77 ± 4.71 | 22.83 ± 7.19 | 0.001 |
| HADS | |||
| Anxiety | 7.89 ± 2.17 | 10.15 ± 3.28 | <0.001 |
| Depression | 7.39 ± 2.16 | 10.34 ± 2.82 | <0.001 |
| Total | 15.28 ± 2.95 | 20.49 ± 5.20 | <0.001 |
5. Discussion
The present study aimed to determine the status of health-promoting behaviors in hemodialysis patients and their association with psychological distress during the COVID-19 pandemic.
According to our findings, the mean score of the HPLPII questionnaire was 120.53 ± 20.35 in hemodialysis patients. Health-promoting behaviors were weaker in dialysis patients than in the control group. They also had lower scores in spiritual growth, stress management, and physical activity but higher scores in health responsibility than the control group. Sarıaslan and Kavurmacı (28) reported that the mean score of health-promoting behaviors was 117.80 ± 37.07 in dialysis patients, which was partially similar to our study. Like our study, sports and physical activity received the lowest score among the health-promoting components. However, Özkaraman et al. (29) reported the mean scores of health-promoting behaviors to be 137.34 ± 35.38, which was higher than in our study. Like the present study, the lowest score of health-promoting behavior belonged to exercise and physical activity in these studies. Given the lower level of health-promoting behaviors in hemodialysis patients, previous studies have examined different behaviors to promote health in dialysis patients, including exercise and physical activity during dialysis and educational programs to increase patients' knowledge. Such programs can significantly promote health behaviors in patients with kidney problems (30).
According to our findings, hemodialysis patients had significantly higher depression scores than the control group. Like our study, Amani Anwar et al. (31) evaluated the depression and anxiety of dialysis patients using the HADS in Jordan. In their study, the mean score for depression was 8.74, which was lower than that in our study. Lifelong dialysis treatment at least three times a week, excessive medication by patients at one time, the economic burden on patients and their families, and changes in family and social relationships are probably among the causes of higher depression in dialysis patients (32).
The case group had anxiety higher than the control group in the present study. Anxiety disorders are common psychiatric disorders that often exist in patients with kidney failure undergoing dialysis (33). Ok and Kutlu (34) found that the patients' mean anxiety score was 4.72 based on the HADS, which differs greatly from our study.
According to our findings, hemodialysis patients had significantly higher coronavirus anxiety than the control group. Consistent with our study, Shi et al. (35) indicated that dialysis patients had higher anxiety during COVID-19. According to a study by Dehghan et al. (36) in Kerman province, the mean anxiety score of dialysis patients was 12.03, which was lower than our study. They also found that 30% of patients had moderate to severe anxiety. It was also mentioned that this higher anxiety in the COVID-19 era could be due to the worry of contracting COVID-19 and its various complications in dialysis patients because of their higher vulnerability.
The present study had limitations. First, the small number of research units decreased the research generalizability. Second, the subjective nature of the questionnaires was not as accurate as the specific psychiatric interview; third, the cross-sectional nature of the study could not determine the cause-effect relationship.
5.1. Conclusions
Our findings indicate that hemodialysis patients have lower scores for health-promoting behaviors and higher levels of hospital depression-anxiety and coronavirus anxiety compared to the control group. Planning and implementing health-promoting projects is necessary for dialysis patients to promote health-promoting behaviors and reduce their anxiety and depression. We suggest that other researchers conduct similar studies with a larger number of samples to investigate different strategies and improve anxiety, depression, and health-promoting behaviors in dialysis patients.
Acknowledgements
References
-
1.
Meguid El Nahas A, Bello AK. Chronic kidney disease: the global challenge. Lancet. 2005;365(9456):331-40. [PubMed ID: 15664230]. https://doi.org/10.1016/S0140-6736(05)17789-7.
-
2.
Gorriz Teruel JL, Otero Gonzalez A. [Social and health impact of advanced chronic kidney disease]. Nefrologia. 2008;28 Suppl 3:7-15. Spanish. [PubMed ID: 19018732].
-
3.
Fallah Mehrabadi E, Pakgohar M, Asadi S, Haghani H. Lifestyle of Elderly People With Osteoporosis and Its Related Factors. Salmand. 2017;12(2):132-45. https://doi.org/10.21859/sija-1202132.
-
4.
Paulus P, Zurhorst G. [Health promotion, health promoting education and social inequality]. Gesundheitswesen. 2001;63:S52-5. German.
-
5.
Luthar SS, Cicchetti D, Becker B. The construct of resilience: a critical evaluation and guidelines for future work. Child Dev. 2000;71(3):543-62. [PubMed ID: 10953923]. [PubMed Central ID: PMC1885202]. https://doi.org/10.1111/1467-8624.00164.
-
6.
Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ. 2018;96(6):414-422D. [PubMed ID: 29904224]. [PubMed Central ID: PMC5996218]. https://doi.org/10.2471/BLT.17.206441.
-
7.
Fukuhara S, Green J, Albert J, Mihara H, Pisoni R, Yamazaki S, et al. Symptoms of depression, prescription of benzodiazepines, and the risk of death in hemodialysis patients in Japan. Kidney Int. 2006;70(10):1866-72. [PubMed ID: 17021611]. https://doi.org/10.1038/sj.ki.5001832.
-
8.
Hedayati SS, Grambow SC, Szczech LA, Stechuchak KM, Allen AS, Bosworth HB. Physician-diagnosed depression as a correlate of hospitalizations in patients receiving long-term hemodialysis. Am J Kidney Dis. 2005;46(4):642-9. [PubMed ID: 16183419]. https://doi.org/10.1053/j.ajkd.2005.07.002.
-
9.
McDade-Montez EA, Christensen AJ, Cvengros JA, Lawton WJ. The role of depression symptoms in dialysis withdrawal. Health Psychol. 2006;25(2):198-204. [PubMed ID: 16569111]. https://doi.org/10.1037/0278-6133.25.2.198.
-
10.
Drayer RA, Piraino B, Reynolds C3, Houck PR, Mazumdar S, Bernardini J, et al. Characteristics of depression in hemodialysis patients: symptoms, quality of life and mortality risk. Gen Hosp Psychiatry. 2006;28(4):306-12. [PubMed ID: 16814629]. https://doi.org/10.1016/j.genhosppsych.2006.03.008.
-
11.
Kurella M, Kimmel PL, Young BS, Chertow GM. Suicide in the United States end-stage renal disease program. J Am Soc Nephrol. 2005;16(3):774-81. [PubMed ID: 15659561]. https://doi.org/10.1681/ASN.2004070550.
-
12.
Palmer S, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, et al. Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int. 2013;84(1):179-91. [PubMed ID: 23486521]. https://doi.org/10.1038/ki.2013.77.
-
13.
Turkistani I, Nuqali A, Badawi M, Taibah O, Alserihy O, Morad M, et al. The prevalence of anxiety and depression among end-stage renal disease patients on hemodialysis in Saudi Arabia. Ren Fail. 2014;36(10):1510-5. [PubMed ID: 25154858]. https://doi.org/10.3109/0886022X.2014.949761.
-
14.
Stasiak CE, Bazan KS, Kuss RS, Schuinski AF, Baroni G. Prevalence of anxiety and depression and its comorbidities in patients with chronic kidney disease on hemodialysis and peritoneal dialysis. J Bras Nefrol. 2014;36(3):325-31. [PubMed ID: 25317615]. https://doi.org/10.5935/0101-2800.20140047.
-
15.
Cukor D, Ver Halen N, Fruchter Y. Anxiety and quality of life in ESRD. Semin Dial. 2013;26(3):265-8. [PubMed ID: 23432416]. https://doi.org/10.1111/sdi.12065.
-
16.
Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007;14(1):82-99. [PubMed ID: 17200048]. https://doi.org/10.1053/j.ackd.2006.10.001.
-
17.
To KK, Tsang OT, Yip CC, Chan KH, Wu TC, Chan JM, et al. Consistent Detection of 2019 Novel Coronavirus in Saliva. Clin Infect Dis. 2020;71(15):841-3. [PubMed ID: 32047895]. [PubMed Central ID: PMC7108139]. https://doi.org/10.1093/cid/ciaa149.
-
18.
Sadoughi M, Hesampour F. [The relationship between anxiety, depression and perceived social support and quality of life among hemodialysis patients]. J Clin Nurs Midw. 2017;6(3):56-71. Persian.
-
19.
Mollaoglu M. Perceived social support, anxiety, and self‐care among patients receiving hemodialysis. Dial Transplant. 2006;35(3):144-55. https://doi.org/10.1002/dat.20002.
-
20.
Walker SN, Sechrist KR, Pender NJ. The Health-Promoting Lifestyle Profile: development and psychometric characteristics. Nurs Res. 1987;36(2):76-81. [PubMed ID: 3644262].
-
21.
Pourmeidani S, Noori A, Shafti SA. [Relationship between life style and marital satisfaction]. J Fam Res. 2014;10(3):331-44. Persian.
-
22.
Mohammadi Zeidi I, Pakpour Hajiagha A, Mohammadi Zeidi B. [Reliability and validity of Persian version of the health-promoting lifestyle profile]. J Mazand Univ Med Sci. 2011;20(1):102-13. Persian.
-
23.
Fathi Ashtiani A, Jafari Kandovan G. Comparison of lifestyle, quality of life and mental health in two military dependent and non-military dependent university personnel. Iran J Mil Med. 2011;13(1):17-24.
-
24.
Kaviani H, Seyfourian H, Sharifi V, Ebrahimkhani N. Reliability and validity of anxiety and depression hospital scales (HADS): Iranian patients with anxiety and depression disorders. Tehran Univ Med J. 2009;67(5):379-85.
-
25.
Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S. The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version. Health Qual Life Outcomes. 2003;1:14. [PubMed ID: 12816545]. [PubMed Central ID: PMC161819]. https://doi.org/10.1186/1477-7525-1-14.
-
26.
Amini P, Maroufizadeh S, Omani Samani R. Evaluating the factor structure, item analyses, and internal consistency of hospital anxiety and depression scale in Iranian infertile patients. Int J Reprod Biomed. 2017;15(5):287-96. [PubMed ID: 28744524]. [PubMed Central ID: PMC5510582].
-
27.
Alipour A, Ghadami A, Alipour Z, Abdollahzadeh H. Preliminary validation of the Corona Disease Anxiety Scale (CDAS) in the Iranian sample. Health Psychology. 2020;8(32):163-75. https://doi.org/10.30473/hpj.2020.52023.4756.
-
28.
Sarıaslan A, Kavurmacı M. Evaluation of healthy lifestyle behaviors and affecting factors of hemodialysis patients. J Prev Epidemiol. 2020;5(2):e19. https://doi.org/10.34172/jpe.2020.19.
-
29.
Özkaraman A, Alparslan GB, Babadağ B, Gökçe S, Gölgeli H, Derin Ö, et al. Evaluation of healthy lifestyle behaviors of hemodialysis patients. Osmangazİ J Med. 2016;38(2):51-61. https://doi.org/10.20515/otd.54752.
-
30.
Sobhy Omran E, Mosaad Ali M, Said Sabry S, Hamido Abosree T. Effectiveness of Educational Program for Health Promoting Lifestyle among Patients (Recipients) with Kidney Transplantation. J Nurs Sci Benha Univ. 2022;3(2):1121-44. https://doi.org/10.21608/jnsbu.2022.255526.
-
31.
Amani Anwar K, Khalifeh AH, Al-Rawashdeh S, Darawad M, Abed M. Depressive symptoms, anxiety, and quality of life in hemodialysis patients and their caregivers: a dyadic analysis. Jpn Psychol Res. 2021;53(1). https://doi.org/10.1111/jpr.12339.
-
32.
Khan A, Khan AH, Adnan AS, Sulaiman SAS, Mushtaq S. Prevalence and predictors of depression among hemodialysis patients: a prospective follow-up study. BMC Public Health. 2019;19(1):531. [PubMed ID: 31072378]. [PubMed Central ID: PMC6507067]. https://doi.org/10.1186/s12889-019-6796-z.
-
33.
Cohen SD, Cukor D, Kimmel PL. Anxiety in Patients Treated with Hemodialysis. Clin J Am Soc Nephrol. 2016;11(12):2250-5. [PubMed ID: 27660303]. [PubMed Central ID: PMC5142059]. https://doi.org/10.2215/CJN.02590316.
-
34.
Ok E, Kutlu FY. Hopelessness, anxiety, depression and treatment adherence in chronic hemodialysis patients. Int J Car Sci. 2019;12(1):423-9.
-
35.
Shi Y, Liao Y, Zhou Y, Liu H, Lei Y, Luo L. Anxiety, depression, and related factors in hemodialysis patients during the lockdown period of COVID- 19 in China: a multicenter study. Psychol Health Med. 2023;28(6):1513-9. [PubMed ID: 35850563]. https://doi.org/10.1080/13548506.2022.2100917.
-
36.
Dehghan M, Namjoo Z, Mohammadi Akbarabadi F, Fooladi Z, Zakeri MA. The relationship between anxiety, stress, spiritual health, and mindfulness among patients undergoing hemodialysis: A survey during the COVID-19 outbreak in Southeast Iran. Health Sci Rep. 2021;4(4). e461. [PubMed ID: 34938901]. [PubMed Central ID: PMC8670730]. https://doi.org/10.1002/hsr2.461.